Kewaunee Scientific Acquires Nu Aire to Enhance Product Portfolio and Market Presence
- Kewaunee Scientific acquires Nu Aire to expand its product portfolio and enhance market reach.
- The acquisition strengthens Kewaunee's manufacturing capabilities and operational efficiencies in the laboratory industry.
- Kewaunee's global presence supports diverse markets while focusing on innovation and excellence in laboratory solutions.
Kewaunee Scientific Expands Product Portfolio with Nu Aire Acquisition
Kewaunee Scientific Corporation, a prominent player in the laboratory and healthcare furniture industry, announces a significant development with its recent acquisition of Nu Aire, a respected manufacturer known for its biological safety cabinets and ultralow freezers. This strategic move aligns with Kewaunee's long-term goal of enhancing its product offerings and expanding its market reach. Founded in 1906 and based in Statesville, North Carolina, Kewaunee has built a reputation for designing, manufacturing, and installing high-quality laboratory and technical furniture solutions. With this acquisition, Kewaunee not only broadens its product line but also strengthens its competitive position within the industry.
The integration of Nu Aire into Kewaunee's operations is expected to yield numerous benefits, including expanded manufacturing capabilities and access to a wider customer base. Nu Aire's established presence in Plymouth, Minnesota, along with its additional facilities in Long Lake, Minnesota, and a distribution center in the Netherlands, complements Kewaunee's existing manufacturing footprint. This synergy between the two companies is anticipated to enhance operational efficiencies and foster innovation in product development. As Kewaunee continues to focus on delivering state-of-the-art solutions for laboratory environments, the acquisition of Nu Aire signifies a commitment to maintaining industry leadership and meeting evolving customer needs.
In addition to its product expansion, Kewaunee maintains a robust international presence, with sales offices located in the U.S., India, Saudi Arabia, and Singapore. This global reach allows the company to cater to diverse markets and leverage regional expertise. As Kewaunee prepares to release its second-quarter fiscal year 2026 financial results on December 10, 2025, the company emphasizes that the successful integration of Nu Aire will play a pivotal role in its future growth trajectory. However, the press release also highlights the potential risks and uncertainties associated with this acquisition, including competition and economic conditions, which could impact overall performance.
Kewaunee’s website serves as a valuable resource for stakeholders seeking further insights into the company’s operations and strategic initiatives. The integration of Nu Aire is set to enhance Kewaunee's existing product portfolio, reinforcing its commitment to innovation and excellence in the laboratory and healthcare sectors. For more information, stakeholders can also visit Nu Aire’s website to explore its extensive range of laboratory products.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

